Loading live market data…

Arcutis Biotherapeutics, Inc.

NASDAQ:ARQT

$26.81 USD

-$0.31 (-1.14%)

Volume
771.51K
Average Volume
1.78M
Market Capitalization
$3.35B
P/E Ratio
-1396.35
Dividend Yield
0.00%
Price Target
$34.00
Year High
$31.77
Year Low
$13.70
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.68

ARQT Estimated and Actual Revenue by Quarter

ARQT Estimated and Actual EPS by Quarter

ARQT Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 -56.58M -53.54M -55.07M -57.59M -54.49M -56.04M
2027-09-30 2 -52.6M -49.77M -51.19M -53.53M -50.65M -52.1M
2027-06-30 2 -48.53M -45.92M -47.23M -49.39M -46.73M -48.07M
2027-03-31 3 -43.9M -41.54M -42.73M -44.68M -42.28M -43.49M
2026-12-31 3 -46.6M -44.09M -45.35M -47.43M -44.88M -46.16M
2026-09-30 4 -40.86M -39.69M -40.27M -41.58M -40.39M -40.99M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 36.78M 39.53M 38.16M 1.35B 1.43B 1.39B
2027-09-30 2 24.94M 26.8M 25.87M 1.26B 1.33B 1.29B
2027-06-30 2 17.46M 18.76M 18.11M 1.16B 1.22B 1.19B
2027-03-31 3 10.39M 11.17M 10.78M 1.05B 1.11B 1.08B
2026-12-31 3 19.07M 20.5M 19.79M 1.11B 1.18B 1.14B
2026-09-30 4 7.39M 19.69M 11.32M 1B 1.03B 1.02B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 172.57M 182.39M 177.5M 2 0.28434 0.30556 0.295
2027-09-30 2 160.41M 169.54M 165M 1 0.19277 0.20716 0.2
2027-06-30 2 148.02M 156.44M 152.25M 1 0.13494 0.14501 0.14
2027-03-31 3 133.9M 141.52M 137.73M 2 0.08032237 0.08631557 0.083333
2026-12-31 3 142.13M 150.22M 146.2M 2 0.14743 0.15843 0.15296
2026-09-30 4 127.92M 131.69M 129.81M 4 0.05709 0.15224 0.087538